124 related articles for article (PubMed ID: 36310778)
1. Association between duration of antipseudomonal beta-lactam therapy and
Hawkins AM; Raux B; Weeda E; Hornback KM
Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e25. PubMed ID: 36310778
[TBL] [Abstract][Full Text] [Related]
2. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti-pseudomonal β-lactam: Does "S" equal success in the presence of resistance to other anti-pseudomonal β-lactams?
Lodise TP; Puzniak LA; Chen LH; Tian Y; Wei R; Im TM; Tartof SY
Pharmacotherapy; 2021 Aug; 41(8):658-667. PubMed ID: 34097763
[TBL] [Abstract][Full Text] [Related]
4. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents.
Mediwala KN; Kohn JE; Bookstaver PB; Justo JA; Rac H; Tucker K; Lashkova L; Dash S; Al-Hasan MN
Am J Infect Control; 2019 Nov; 47(11):1284-1289. PubMed ID: 31221448
[TBL] [Abstract][Full Text] [Related]
5. Quantifying Gram-Negative Resistance to Empiric Treatment After Repeat ExpoSure To AntimicRobial Therapy (RESTART).
Wibisono A; Harb G; Crotty M; Rahmanzadeh K; Alexander J; Hunter L; Dominguez E
Open Forum Infect Dis; 2022 Dec; 9(12):ofac659. PubMed ID: 36582770
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.
Al-Jaghbeer MJ; Justo JA; Owens W; Kohn J; Bookstaver PB; Hucks J; Al-Hasan MN
Infection; 2018 Aug; 46(4):487-494. PubMed ID: 29752649
[TBL] [Abstract][Full Text] [Related]
7. Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.
Ray MJ; Strnad LC; Tucker KJ; Furuno JP; Lofgren ET; McCracken CM; Park H; Gerber JS; McGregor JC
Clin Infect Dis; 2024 May; ():. PubMed ID: 38743579
[TBL] [Abstract][Full Text] [Related]
8. Impact of a syndrome-based stewardship intervention on antipseudomonal beta-lactam use, antimicrobial resistance,
Mena Lora AJ; Burgos R; Hunt AE; Wang Y; Huber D; Sanchez L; Ali M; Krill C; Takhsh E; Bleasdale SC
Antimicrob Steward Healthc Epidemiol; 2024; 4(1):e31. PubMed ID: 38500719
[TBL] [Abstract][Full Text] [Related]
9. Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.
Teshome BF; Vouri SM; Hampton N; Kollef MH; Micek ST
Pharmacotherapy; 2019 Mar; 39(3):261-270. PubMed ID: 30506852
[TBL] [Abstract][Full Text] [Related]
10. Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
Lee JD; Heintz BH; Mosher HJ; Livorsi DJ; Egge JA; Lund BC
Clin Infect Dis; 2021 Oct; 73(7):e1579-e1586. PubMed ID: 33382398
[TBL] [Abstract][Full Text] [Related]
11. Evaluating
Keats KR; Stitt TM; Chastain DB; Jivan BP; Matznick E; Waller JL; Clemmons AB
J Oncol Pharm Pract; 2022 Apr; 28(3):542-550. PubMed ID: 33663290
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic use and duration in association with Clostridioides difficile infection in a tertiary academic medical center: A retrospective case-control study.
Thabit AK; Varugehese CA; Levine AR
Anaerobe; 2019 Oct; 59():126-130. PubMed ID: 31254655
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
Wombwell E; Patterson ME; Bransteitter B; Gillen LR
Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
[TBL] [Abstract][Full Text] [Related]
14. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study.
Younas M; Royer J; Weissman SB; Waites KS; Dash S; Rac H; Bookstaver PB; Justo JA; Bell L; Maki A; Al-Hasan MN
Infection; 2020 Feb; 48(1):129-132. PubMed ID: 31677084
[TBL] [Abstract][Full Text] [Related]
15. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
[TBL] [Abstract][Full Text] [Related]
16. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network.
Rhea S; Jones K; Endres-Dighe S; Munoz B; Weber DJ; Hilscher R; MacFarquhar J; Sickbert-Bennett E; DiBiase L; Marx A; Rineer J; Lewis J; Bobashev G;
PLoS One; 2020; 15(6):e0234031. PubMed ID: 32525887
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
18. The effect of probiotics on the incidence of Clostridioides difficile: Retrospective cohort analysis.
Saltzman T; Fazzari M; Chung S; Cunha BA; Blum S
Am J Infect Control; 2020 Feb; 48(2):184-188. PubMed ID: 31606256
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Antimicrobial Stewardship Mandate on Multidrug-Resistant Organisms and
Chahine EB; Cook RO; Carrion T; Sarkissian RJ
Sr Care Pharm; 2022 Aug; 37(8):345-356. PubMed ID: 35879843
[No Abstract] [Full Text] [Related]
20. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
Finn E; Andersson FL; Madin-Warburton M
BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
